Company: PCRX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001396814-25-000041
Chunk: 105

Company: Pacira BioSciences, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 105
---
 and administrative294,099 269,441 254,516 Amortization of acquired intangible assets57,288 57,288 57,288 Goodwill impairment163,243 — — Contingent consideration gains, restructuring charges and other7,702 (352)10,903 Total operating expenses774,337 587,303 606,799 (Loss) income from operations(73,371)87,675 60,024 Other income (expense):   Interest income19,689 11,444 4,542 Interest expense(16,569)(20,306)(39,976)Gain (loss) on early extinguishment of debt7,518 (16,926)— Other, net(373)(186)(11,288)Total other income (expense), net10,265 (25,974)(46,722)(Loss) income before income taxes(63,106)61,701 13,302 Income tax (expense) benefit(36,454)(19,746)2,607 Net (loss) income$(99,560)$41,955 $15,909 Net (loss) income per share:   Basic net (loss) income per common share$(2.15)$0.91 $0.35 Diluted net (loss) income per common share$(2.15)$0.89 $0.34 Weighted average common shares outstanding:   Basic46,245 46,222 45,521 Diluted46,245 51,979 46,538 

See accompanying notes to consolidated financial statements.

Pacira BioSciences, Inc.  |  2024 Annual Report on Form 10-K  |  Page F-6

PACIRA BIOSCIENCES, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(In thousands) Year Ended December 31, 202420232022Net (loss) income$(99,560)$41,955 $15,909 Other comprehensive income (loss):   Net unrealized gain (loss) on investments, net of tax66 647 (662)Foreign currency translation adjustments30 (20)115 Total other comprehensive income (loss)96 627 (547)Comprehensive (loss) income$(99,464)$42,582 $15,362